S-Biomedic NV is a Belgium-based life science company that has been making waves since its establishment in 2014. Focused on skin health, the company stands out with its pioneering work in developing Pro- and Post-biotic ingredients sourced from true skin commensals. With a focus on delivering novel active ingredients for use in cosmetic formulations and offering unique positioning and clinically substantiated efficacy claims, S-Biomedic is redefining skincare and dermatology. The company's groundbreaking proprietary technology platform and expertise enable it to capitalize on the natural power of the skin microbiome, paving the way for novel solutions for a wide variety of skin conditions. S-Biomedic recently secured funding through a Venture Round - S investment in October 2019, with The European Innovation Council backing its innovative approach and promising trajectory.